A 52-year-old man with multiple myeloma is started on high-dose melphalan followed by autologous stem cell transplantation. Which is the most common acute hematological toxicity expected within the first 2–3 weeks post-transplantation?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.